Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242317031 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ghazi O Bou Ghanem und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Eye Institute, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Optic Disk. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NICHD NIH HHS, Stuart Therapeutics, Inc..
Abstract (Originalsprache)
The structural and biomechanical properties of collagen-rich ocular tissues, such as the sclera, are integral to ocular function. The degradation of collagen in such tissues is associated with debilitating ophthalmic diseases such as glaucoma and myopia, which often lead to visual impairment. Collagen mimetic peptides (CMPs) have emerged as an effective treatment to repair damaged collagen in tissues of the optic projection, such as the retina and optic nerve. In this study, we used atomic force microscopy (AFM) to assess the potential of CMPs in restoring tissue stiffness in the optic nerve head (ONH), including the peripapillary sclera (PPS) and the glial lamina. Using rat ONH tissue sections, we induced collagen damage with MMP-1, followed by treatment with CMP-3 or vehicle. MMP-1 significantly reduced the Young’s modulus of both the PPS and the glial lamina, indicating tissue softening. Subsequent CMP-3 treatment partially restored tissue stiffness in both the PPS and the glial lamina. Immunohistochemical analyses revealed reduced collagen fragmentation after MMP-1 digestion in CMP-3-treated tissues compared to vehicle controls. In summary, these results demonstrate the potential of CMPs to restore collagen stiffness and structure in ONH tissues following enzymatic damage. CMPs may offer a promising therapeutic avenue for preserving vision in ocular disorders involving collagen remodeling and degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt Eye Institute, Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Vanderbilt Institute of Nanoscale Science and Engineering, Vanderbilt University, Nashville, TN 37212, USA.
- Stuart Therapeutics, Inc., Stuart, FL 34994, USA.
ORCID-Profile: Ghazi O Bou Ghanem, Robert O Baratta, Eric Schlumpf, Lauren K Wareham, David J Calkins
Förderung
- NIAMS NIH HHS
- NICHD NIH HHS
- Stuart Therapeutics, Inc.
- Vanderbilt Institute of Nanoscale Science and Engineering
- VINSE pilot grant
Zitieren
APA
Bou Ghanem, G. O., Koktysh, D., Baratta, R. O., Del Buono, B. J., Schlumpf, E., Wareham, L. K., & Calkins, D. J. (2023). Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242317031
Vancouver
Bou Ghanem GO, Koktysh D, Baratta RO, Del Buono BJ, Schlumpf E, Wareham LK, et al. Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242317031
BibTeX
@article{BouGhanem2023,
author = {Bou Ghanem, Ghazi O and Koktysh, Dmitry and Baratta, Robert O and Del Buono, Brian J and Schlumpf, Eric and Wareham, Lauren K and Calkins, David J},
title = {Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242317031}
}
EUVIMED